Metabolism and Drug Interactions of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors in Transplant Patients: Are the Statins Mechanistically Similar?

This publication has 95 references indexed in Scilit:

• TISSUE-SELECTIVE UPTAKE OF PRAVASTATIN IN RATS: CONTRIBUTION OF A SPECIFIC CARRIER-MEDIATED UPTAKE SYSTEM
  Biopharmaceutics & Drug Disposition, 1996
• Pravastatin‐induced rhabdomyolysis in a patient with mixed connective tissue disease
  Arthritis & Rheumatism, 1996
• Effects of Atorvastatin, an HMG‐CoA Reductase Inhibitor, on Hepatic Oxidative Metabolism of Antipyrine
  The Journal of Clinical Pharmacology, 1996
• Cytosolic Ca2+ Increase and Cell Damage in L6 Rat Myoblasts by HMG-CoA Reductase Inhibitors
  Biochemical and Biophysical Research Communications, 1994
• Cytochrome P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liver
  Life Sciences, 1993
• Biotransformation of Pravastatin Sodium(I): Mechanisms of Enzymatic Transformation and Epimerization of an Allylic Hydroxy Group of Pravastatin Sodium
  Biochemical and Biophysical Research Communications, 1993
• Elevation of fasting serum lipids in patients treated with low-dose cyclosporine for severe plaque-type psoriasis: An assessment of clinical significance when viewed as a risk factor for cardiovascular disease
  Journal of the American Academy of Dermatology, 1992
• Single‐Dose Pharmacokinetics of Pravastatin and Metabolites in Patients with Renal Impairment
  The Journal of Clinical Pharmacology, 1992
• Studies on the metabolic inversion of the 6′ chiral center or simvastatin
  Biochemical and Biophysical Research Communications, 1991
• Longitudinal Study of Cyclosporine and Lipids in Patients Undergoing Bone Marrow Transplantation
  The Journal of Clinical Pharmacology, 1990